Skip to main content

Genome-wide insights into generalised anxiety using a dimensional symptom severity approach.

Publication ,  Journal Article
Skelton, M; Mitchell, BL; Assary, E; Li, D; Morneau-Vaillancourt, G; Murphy, AE; Ter Kuile, AR; Wang, R; Adams, MJ; Byrne, EM; Corfield, EC ...
Published in: medRxiv
July 11, 2025

We performed a genome-wide association meta-analysis of generalised anxiety symptom severity in 696,563 individuals of European ancestry from 14 cohorts. We identified 82 independent genome-wide significant variants within 76 loci, 41 of which were novel for anxiety. SNP-based heritability was 5.9% (SE = 0.19%). Polygenic scores were significantly associated with anxiety symptom severity and disorder in European, African, and South Asian ancestry samples (r2=1.2%-3.4%). Significant genetic correlations were estimated with numerous mental and physical health traits, including case-control anxiety, neuroticism and depression (rg=0.71-0.86), irritable bowel syndrome (rg=0.57), coronary artery disease, endometriosis, and migraine (rg=0.20-0.27). Gene-based and pathway analyses implicated synaptic and axonal processes, with enriched expression in the brain. These findings highlight the additional value of a dimensional approach in anxiety genetics.

Duke Scholars

Published In

medRxiv

DOI

Publication Date

July 11, 2025

Location

United States
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Skelton, M., Mitchell, B. L., Assary, E., Li, D., Morneau-Vaillancourt, G., Murphy, A. E., … Eley, T. C. (2025). Genome-wide insights into generalised anxiety using a dimensional symptom severity approach. MedRxiv. https://doi.org/10.1101/2025.07.10.25331321
Skelton, Megan, Brittany L. Mitchell, Elham Assary, Danyang Li, Genevieve Morneau-Vaillancourt, Alan E. Murphy, Abigail R. Ter Kuile, et al. “Genome-wide insights into generalised anxiety using a dimensional symptom severity approach.MedRxiv, July 11, 2025. https://doi.org/10.1101/2025.07.10.25331321.
Skelton M, Mitchell BL, Assary E, Li D, Morneau-Vaillancourt G, Murphy AE, et al. Genome-wide insights into generalised anxiety using a dimensional symptom severity approach. medRxiv. 2025 Jul 11;
Skelton, Megan, et al. “Genome-wide insights into generalised anxiety using a dimensional symptom severity approach.MedRxiv, July 2025. Pubmed, doi:10.1101/2025.07.10.25331321.
Skelton M, Mitchell BL, Assary E, Li D, Morneau-Vaillancourt G, Murphy AE, Ter Kuile AR, Wang R, Adams MJ, Byrne EM, Corfield EC, Grimes PZ, Hannigan LJ, Hu J, Koiv K, Kwong AS, Papiol S, Pettersen JH, Pistis G, Castelao E, Strom NI, van der Most PJ, Anxiety Disorders Working Group of the Psychiatric Genomics Consortium, GLAD+ authors, Lifelines Cohort Study, NIHR Bioresource, Protect-AD Consortium, Andreassen OA, Erhardt-Lehmann A, Havdahl A, Skene N, Verhulst B, Weber H, Armour C, Ask H, Copeland WE, Dannlowski U, Deckert J, Domschke K, Hickie IB, Lehto K, Lonsdorf TB, Lueken U, Lupton MK, Medland SE, McIntosh AM, Oldehinkel AJ, Preisig M, Reif A, Snieder H, Walters JTR, Wray NR, Hartman CA, Martin NG, Hettema JM, Breen G, Coleman JR, Eley TC. Genome-wide insights into generalised anxiety using a dimensional symptom severity approach. medRxiv. 2025 Jul 11;

Published In

medRxiv

DOI

Publication Date

July 11, 2025

Location

United States